Rydar Equities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.44M Buy
1,565
+3
+0.2% +$3.04K 1.11% 32
2025
Q4
$1.68M Buy
1,562
+4
+0.3% +$3.83K 1.31% 26
2025
Q3
$1.31M Sell
1,558
-45
-3% -$33.5K 1.05% 31
2025
Q2
$1.25M Buy
+1,603
New +$1.25M 0.99% 33

Other funds holding LLY

Rydar Equities's LLY Position: Q1 2026 in Review

Rydar Equities increased its Eli Lilly (LLY) stake by 0.19% in Q1 2026, buying an estimated $3.04K and bringing the position to 1,565 shares worth $1.44M. The position accounts for 1.11% of the portfolio, ranked #32.

Rydar Equities first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.68M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Rydar Equities held 1,565 shares of Eli Lilly worth $1.44M as of Q1 2026.
  • Rydar Equities bought 3 Eli Lilly shares in Q1 2026, an estimated $3.04K.
  • Eli Lilly made up 1.11% of Rydar Equities's portfolio in Q1 2026, its #32 holding.
  • Rydar Equities first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
  • Rydar Equities's Eli Lilly position peaked at $1.68M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Rydar Equities's 13F filing for Q1 2026, filed 13 Apr 2026.